Industry: Biotechnology (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2025-04-28 | Amended | $904,859 | $584,146 | Equity Only | 06b | SEC link |
| 2024-04-12 | New | $320,713 | $320,713 | Equity Only | 06b | SEC link |
| 2023-05-09 | Amended | $48,882,447 | $759,393 | Equity Only | 06b | SEC link |
| 2022-05-24 | Amended | $48,123,054 | $10,051,411 | Equity Only | 06b | SEC link |
| 2021-04-28 | New | $38,071,643 | $38,071,643 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| Peng Liang | Director, Executive, Promoter |
| Joshua Liang | Director, Executive |
| Dong Lyu | Director |
| Xiaodong Wang | Director |
| Ting Xiao | Director |
| Guangyu Xu | Director |